Data shows that cumulative sales of remdesivir was Rs 510 crore in January 2021, while for favipiravir it was Rs 471 crore
from Latest News https://ift.tt/3rK84WT
Thursday, 11 February 2021
Covid-19 drugs among top-selling brands for pharma players in India
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment